Penetrating Macrophage-Based Nanoformulation for Periodontitis Treatment
Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing...
Saved in:
Published in | ACS nano Vol. 16; no. 11; pp. 18253 - 18265 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
22.11.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 1936-0851 1936-086X 1936-086X |
DOI | 10.1021/acsnano.2c05923 |
Cover
Abstract | Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro. |
---|---|
AbstractList | Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro.Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro. Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both and . Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.) acts as a key mediator in subverting the homeostasis of the local immune system. On the one hand, P.g. inhibits phagocytosis and the killing capacity of immune cells. On the other hand, P.g. increases selective cytokine release, which is beneficial to its further proliferation. Here, we prepared a penetrating macrophage-based nanoformulation (MZ@PNM)-encapsulating hydrogel (MZ@PNM@GCP) that responded to the periodontitis microenvironment. MZ@PNM targeted P.g. via the Toll-like receptor complex 2/1 (TLR2/1) on its macrophage-mimicking membrane, then directly killed P.g. through disruption of bacterial structural integrity by the cationic nanoparticles and intracellular release of an antibacterial drug, metronidazole (MZ). Meanwhile, MZ@PNM interrupted the specific binding of P.g. to immune cells and neutralized complement component 5a (C5a), preventing P.g. subversion of periodontal host immune response. Overall, MZ@PNM@GCP showed potent efficacy in periodontitis treatment, restoring local immune function and killing pathogenic bacteria, while exhibiting favorable biocompatibility, all of which have been demonstrated both in vivo and in vitro. |
Author | Wang, Ziyao Xu, Junchao Bao, Lin Ma, Chao Cong, Yalin Zhao, Yuliang Chen, Chunying Xu, Weihua Yan, Na Liu, Guolin |
AuthorAffiliation | CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience Institute of Genetics and Developmental Biology Liangxiang Hospital |
AuthorAffiliation_xml | – name: Institute of Genetics and Developmental Biology – name: Liangxiang Hospital – name: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience |
Author_xml | – sequence: 1 givenname: Na orcidid: 0000-0003-1900-6405 surname: Yan fullname: Yan, Na organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience – sequence: 2 givenname: Junchao surname: Xu fullname: Xu, Junchao organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience – sequence: 3 givenname: Guolin surname: Liu fullname: Liu, Guolin organization: Liangxiang Hospital – sequence: 4 givenname: Chao surname: Ma fullname: Ma, Chao – sequence: 5 givenname: Lin surname: Bao fullname: Bao, Lin organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience – sequence: 6 givenname: Yalin surname: Cong fullname: Cong, Yalin organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience – sequence: 7 givenname: Ziyao surname: Wang fullname: Wang, Ziyao organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience – sequence: 8 givenname: Yuliang orcidid: 0000-0002-9586-9360 surname: Zhao fullname: Zhao, Yuliang email: zhaoyl@nanoctr.cn organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience – sequence: 9 givenname: Weihua surname: Xu fullname: Xu, Weihua email: whxu@genetics.ac.cn organization: Institute of Genetics and Developmental Biology – sequence: 10 givenname: Chunying orcidid: 0000-0002-6027-0315 surname: Chen fullname: Chen, Chunying email: chenchy@nanoctr.cn organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36288552$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kD1PwzAQhi1URFtgZkMZkVCoP-LYGaECilQ-BpDYIie5lFSJXWxn4N9jaOiABNOd7p73pHumaKSNBoROCL4gmJKZKp1W2lzQEvOMsj00IRlLYyzT19Gu52SMps6tMeZCivQAjVlKpeScTtDiCTR4q3yjV9G9Kq3ZvKkVxFfKQRU9hNu1sV3fBsDoKPTRE9jGVEb7xjcueragfAfaH6H9WrUOjod6iF5urp_ni3j5eHs3v1zGijHm46xOiiThWFSS4lRyQQTlYVLUUoBSRGBaKcUSmmGuSJnxgqcgiwLzSspEAjtEZ9u7G2vee3A-7xpXQtsqDaZ3ORU04yQRmAX0dED7ooMq39imU_Yj__k-ALMtEN52zkK9QwjOv_zmg9988BsS_FeibPy3m-Cwaf_JnW9zYZGvTW91cPQn_Qnjfo9v |
CitedBy_id | crossref_primary_10_3390_gels9030245 crossref_primary_10_1186_s13018_023_04120_w crossref_primary_10_1016_j_mtbio_2025_101638 crossref_primary_10_1039_D3TB03070A crossref_primary_10_3390_pharmaceutics16091175 crossref_primary_10_1002_adfm_202418407 crossref_primary_10_3389_fbioe_2024_1380528 crossref_primary_10_1002_advs_202302029 crossref_primary_10_34133_research_0478 crossref_primary_10_1186_s12951_024_02389_5 crossref_primary_10_1002_smll_202306191 crossref_primary_10_1021_acsnano_4c02316 crossref_primary_10_1016_j_xcrp_2024_102205 crossref_primary_10_1186_s11671_023_03946_x crossref_primary_10_1016_j_cej_2024_158338 crossref_primary_10_1021_acsnano_3c00470 crossref_primary_10_1021_acsbiomaterials_3c00452 crossref_primary_10_1016_j_heliyon_2024_e32036 crossref_primary_10_1021_acsbiomaterials_3c00454 crossref_primary_10_1080_20002297_2024_2361403 crossref_primary_10_1186_s12951_023_01909_z crossref_primary_10_1002_adma_202305633 crossref_primary_10_1080_17435889_2025_2469492 crossref_primary_10_1016_j_phrs_2023_107022 crossref_primary_10_1016_j_jconrel_2024_11_044 crossref_primary_10_1016_j_biopha_2025_117836 crossref_primary_10_1021_acsami_4c17436 crossref_primary_10_1021_acsabm_3c01213 crossref_primary_10_1021_acsnano_3c00578 crossref_primary_10_1016_j_actbio_2024_10_008 crossref_primary_10_1016_j_biopha_2023_114688 crossref_primary_10_1016_j_cej_2024_155694 crossref_primary_10_1186_s12951_023_02261_y crossref_primary_10_2174_1389201024666230821090222 crossref_primary_10_1002_sstr_202300281 crossref_primary_10_2147_IJN_S497590 crossref_primary_10_1016_j_cej_2024_157433 crossref_primary_10_1039_D4NR02480J crossref_primary_10_1186_s12951_024_02801_0 crossref_primary_10_1002_advs_202403786 crossref_primary_10_1021_acs_inorgchem_4c01189 crossref_primary_10_3390_ijms24043158 crossref_primary_10_3390_ijms26072894 crossref_primary_10_1002_smll_202400771 crossref_primary_10_1016_j_cej_2024_157660 crossref_primary_10_1088_1748_605X_ad4aaa crossref_primary_10_1002_adfm_202301062 crossref_primary_10_1016_j_colsurfb_2025_114604 crossref_primary_10_1002_smtd_202301178 crossref_primary_10_1021_acsnano_3c06711 crossref_primary_10_1021_acsbiomaterials_4c00220 crossref_primary_10_2147_IJN_S465959 crossref_primary_10_1007_s10753_024_02168_2 crossref_primary_10_3389_fphar_2024_1533964 |
Cites_doi | 10.1128/IAI.01069-16 10.1038/nrd3669 10.1002/adma.201804023 10.1016/j.matt.2021.08.015 10.1021/ja301167y 10.1016/j.matt.2021.11.017 10.1111/j.1600-051X.2010.01678.x 10.1016/j.biomaterials.2018.05.034 10.1038/s41551-017-0115-8 10.1038/s41577-020-00488-6 10.1002/btm2.10197 10.1902/jop.2013.130280 10.1146/annurev.immunol.23.021704.115816 10.1021/nn3008383 10.2147/IJN.S244849 10.1902/jop.2005.76.9.1601 10.1038/s41579-018-0089-x 10.1021/acsnano.9b03237 10.1021/acsnano.6b03148 10.1038/s41579-020-0420-1 10.1021/acsnano.6b04207 10.1021/acs.nanolett.8b01236 10.1038/nri1391 10.1002/adma.201905145 10.1007/s00253-010-2687-z 10.1038/nnano.2009.153 10.1038/s41565-021-00923-2 10.1034/j.1600-0757.2003.03105.x 10.1002/adma.202005423 10.1126/scitranslmed.aat0797 10.1038/s41565-018-0254-4 10.1021/acsami.0c17235 10.1111/jcpe.12732 10.1016/j.immuni.2011.05.006 10.1016/j.biomaterials.2020.120159 10.1016/j.ijantimicag.2009.12.011 10.1016/j.apmt.2019.100505 10.1002/adfm.201801355 10.1038/nmicrobiol.2016.162 10.1016/j.cell.2006.02.015 10.1021/jacs.5b11411 10.1002/smll.202006484 10.1088/1361-6528/aaa7c7 10.1016/j.chom.2014.05.012 10.1016/j.chom.2011.10.006 |
ContentType | Journal Article |
Copyright | 2022 American Chemical Society |
Copyright_xml | – notice: 2022 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/acsnano.2c05923 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1936-086X |
EndPage | 18265 |
ExternalDocumentID | 36288552 10_1021_acsnano_2c05923 a172996577 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .K2 23M 4.4 55A 5GY 5VS 6J9 7~N AABXI ABFRP ABMVS ABQRX ABUCX ACGFO ACGFS ACS ADHLV AEESW AENEX AFEFF AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ CS3 EBS ED~ F5P GGK GNL IH9 IHE JG~ P2P RNS ROL UI2 VF5 VG9 W1F XKZ YZZ AAHBH AAYXX ABBLG ABJNI ABLBI ACBEA ADHGD BAANH CITATION CUPRZ CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-a333t-9f4b44507d82068571725b44bf87eaa1702daa342905a1c95b56e8bb05d8848e3 |
IEDL.DBID | ACS |
ISSN | 1936-0851 1936-086X |
IngestDate | Fri Jul 11 13:32:47 EDT 2025 Mon Jul 21 06:04:15 EDT 2025 Thu Apr 24 22:59:39 EDT 2025 Tue Jul 01 03:37:32 EDT 2025 Thu Nov 24 04:02:03 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Porphyromonas gingivalis membrane cloaking nanoparticle periodontitis treatment responsive hydrogel host immune dysfunction |
Language | English |
License | https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a333t-9f4b44507d82068571725b44bf87eaa1702daa342905a1c95b56e8bb05d8848e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-1900-6405 0000-0002-9586-9360 0000-0002-6027-0315 |
PMID | 36288552 |
PQID | 2729514703 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_2729514703 pubmed_primary_36288552 crossref_primary_10_1021_acsnano_2c05923 crossref_citationtrail_10_1021_acsnano_2c05923 acs_journals_10_1021_acsnano_2c05923 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20221122 2022-11-22 |
PublicationDateYYYYMMDD | 2022-11-22 |
PublicationDate_xml | – month: 11 year: 2022 text: 20221122 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ACS nano |
PublicationTitleAlternate | ACS Nano |
PublicationYear | 2022 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref45/cit45 ref6/cit6 ref36/cit36 ref3/cit3 ref27/cit27 ref18/cit18 ref11/cit11 ref25/cit25 ref16/cit16 ref29/cit29 ref32/cit32 ref23/cit23 ref39/cit39 ref14/cit14 ref8/cit8 ref5/cit5 ref31/cit31 ref2/cit2 ref43/cit43 ref34/cit34 ref37/cit37 ref28/cit28 ref40/cit40 ref20/cit20 ref17/cit17 ref10/cit10 ref26/cit26 ref35/cit35 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 ref42/cit42 ref41/cit41 ref22/cit22 ref13/cit13 ref33/cit33 ref4/cit4 ref30/cit30 ref1/cit1 ref24/cit24 ref38/cit38 ref44/cit44 ref7/cit7 |
References_xml | – ident: ref42/cit42 doi: 10.1128/IAI.01069-16 – ident: ref8/cit8 doi: 10.1038/nrd3669 – ident: ref11/cit11 doi: 10.1002/adma.201804023 – ident: ref13/cit13 doi: 10.1016/j.matt.2021.08.015 – ident: ref29/cit29 doi: 10.1021/ja301167y – ident: ref2/cit2 doi: 10.1016/j.matt.2021.11.017 – ident: ref25/cit25 doi: 10.1111/j.1600-051X.2010.01678.x – ident: ref39/cit39 doi: 10.1016/j.biomaterials.2018.05.034 – ident: ref40/cit40 doi: 10.1038/s41551-017-0115-8 – ident: ref4/cit4 doi: 10.1038/s41577-020-00488-6 – ident: ref23/cit23 doi: 10.1002/btm2.10197 – ident: ref7/cit7 doi: 10.1902/jop.2013.130280 – ident: ref12/cit12 doi: 10.1146/annurev.immunol.23.021704.115816 – ident: ref34/cit34 doi: 10.1021/nn3008383 – ident: ref18/cit18 doi: 10.2147/IJN.S244849 – ident: ref1/cit1 doi: 10.1902/jop.2005.76.9.1601 – ident: ref5/cit5 doi: 10.1038/s41579-018-0089-x – ident: ref44/cit44 doi: 10.1021/acsnano.9b03237 – ident: ref10/cit10 doi: 10.1021/acsnano.6b03148 – ident: ref28/cit28 doi: 10.1038/s41579-020-0420-1 – ident: ref36/cit36 doi: 10.1021/acsnano.6b04207 – ident: ref19/cit19 doi: 10.1021/acs.nanolett.8b01236 – ident: ref27/cit27 doi: 10.1038/nri1391 – ident: ref41/cit41 doi: 10.1002/adma.201905145 – ident: ref31/cit31 doi: 10.1007/s00253-010-2687-z – ident: ref30/cit30 doi: 10.1038/nnano.2009.153 – ident: ref43/cit43 doi: 10.1038/s41565-021-00923-2 – ident: ref24/cit24 doi: 10.1034/j.1600-0757.2003.03105.x – ident: ref32/cit32 doi: 10.1002/adma.202005423 – ident: ref6/cit6 doi: 10.1126/scitranslmed.aat0797 – ident: ref14/cit14 doi: 10.1038/s41565-018-0254-4 – ident: ref21/cit21 doi: 10.1021/acsami.0c17235 – ident: ref3/cit3 doi: 10.1111/jcpe.12732 – ident: ref9/cit9 doi: 10.1016/j.immuni.2011.05.006 – ident: ref16/cit16 doi: 10.1016/j.biomaterials.2020.120159 – ident: ref37/cit37 doi: 10.1016/j.ijantimicag.2009.12.011 – ident: ref22/cit22 doi: 10.1016/j.apmt.2019.100505 – ident: ref15/cit15 doi: 10.1002/adfm.201801355 – ident: ref35/cit35 doi: 10.1038/nmicrobiol.2016.162 – ident: ref26/cit26 doi: 10.1016/j.cell.2006.02.015 – ident: ref33/cit33 doi: 10.1021/jacs.5b11411 – ident: ref20/cit20 doi: 10.1002/smll.202006484 – ident: ref17/cit17 doi: 10.1088/1361-6528/aaa7c7 – ident: ref38/cit38 doi: 10.1016/j.chom.2014.05.012 – ident: ref45/cit45 doi: 10.1016/j.chom.2011.10.006 |
SSID | ssj0057876 |
Score | 2.61595 |
Snippet | Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. Porphyromonas gingivalis (P.g.)... Periodontitis is a chronic inflammatory disease caused by the interaction of oral microorganisms with the host immune response. (P.g.) acts as a key mediator... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 18253 |
SubjectTerms | Cytokines Humans Macrophages - metabolism Periodontitis - drug therapy Periodontitis - metabolism Porphyromonas gingivalis - physiology |
Title | Penetrating Macrophage-Based Nanoformulation for Periodontitis Treatment |
URI | http://dx.doi.org/10.1021/acsnano.2c05923 https://www.ncbi.nlm.nih.gov/pubmed/36288552 https://www.proquest.com/docview/2729514703 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8NAEF60vuiD91EvIvTBl43JHjketViKUCnYQt_CHlkFJRGTvvjrnc1RL4q-JSG7JDOzM98wu98g1AuM5CQKIC1R0mDGaYjjkCgcGqMEI0J4nj07PLoPhlN2N-OzT7LonxV84l8JVWQiy12iAAkQuorWSABGZlFQ_6F1utbugrqADAkyoIgFi8-vCWwYUsX3MLQEW1YxZrBV784qKmpCu7Xk2Z2X0lXvv4kb__78bbTZIE3nujaNHbSSZrto4wv_4B4ajsHTVby52aMzErab1xP4F3wDoU074HhzC2mbBl8OXDtjGAmJbEXEWjiTdpf6PpoObif9IW5aK2BBKS1xbJhkDLCgtvztEYekjnB4Ik0UpkL4oUe0EBSClceFr2IueZBGUnpcRxGLUnqAOlmepUfICXUAc1CpY-MxA06L6hhuYqEZKIPKLuqBDJJmaRRJVfUmftIIJmkE00Vuq5BENfTktkvGy_IBl4sBrzUzx_JXL1oNJ7B6bElEZGk-LxICuQVARnB7XXRYq34xGbWdmDknx__7gRO0TuzRCN_HhJyiTvk2T88AsJTyvDLVDz2d5ZU |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB2VcgAO7EtZg9QDl5TES5ZjqagCtFURrdRbZGcBCZQg0l74esZpEjZVglsSxSMv45k3GvsNQNOKJSeOhWFJIGOdcWrrrk0C3Y7jQDAihGGou8P9geWN2e2ET2pglHdhsBMZSsryJP4nu4B5id8SkaQtEiAgIHQJlhGKEFWsod15KG2vUj9rnkfGOBnBREXm80uA8kZB9t0bLYCYuavpbsB91cn8hMlzazaVreD9B3_jf0axCesF7tTac0XZglqUbMPaFzbCHfCGaPdyFt3kUesLVdvrCa2NfoWOLtTQDKcK4BblvjR81obYEsPanJY100blmfVdGHevRx1PLwot6IJSOtXdmEnGEBmGis3d4RjiEY5fZOzYkRCmbZBQCIquy-DCDFwuuRU5Uho8dBzmRHQP6kmaRAeg2aGFMqgM3dhgMZowGrr44oqQ4ZpQ2YAmzoFfbJTMz3PgxPSLifGLiWlAq1wXPyjIylXNjJfFDS6qBq9zno7Fv56XC-3jXlIJEpFE6SzzCUYaCCDRCDZgf64BlTCq6jJzTg7_NoAzWPFG_Z7fuxncHcEqUZcmTFMn5Bjq07dZdIJQZipPc-39AFJG7fY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8NAEB60guiD91HPCH3wJTXZI8djrZZ6tBS04FvYzWYVlLSY9sVf72y6LR4U9C0J2WWP2ZlvmJ1vAGqBlpxEAbolqdQu4zR045Ckbqh1KhgRwvNM7nCnG7T77PaJP9mkMJMLg4MosKeiDOKbUz1U2jIM-Bf4PRf5oE5SBAWELsKSCdqZgg2N5sNU_xoRDCaxZPSVEVDMCH1-dWAsUlp8t0hzYGZpblrr0J8NtLxl8lofj2Q9_fjB4fjfmWzAmsWfTmMiMJuwkOVbsPqFlXAb2j3UfyWbbv7sdISp8fWCWse9RIOnHFTHAwN0bdkvB5-dHrZE97akZy2cx-nd9R3ot64fm23XFlxwBaV05MaaScYQISrD6h5xdPUIxy9SR2EmhB96RAlB0YR5XPhpzCUPskhKj6soYlFGd6GSD_JsH5xQBdgHlSrWHtOoyqiK8SUWiuG-UFmFGq5BYg9MkZSxcOIndmESuzBVqE_3JkktabmpnfE2v8H5rMFwwtcx_9ez6WYneKZMoETk2WBcJAQ9DgSSqAyrsDeRglln1NRn5pwc_G0Cp7Dcu2ol9zfdu0NYISZ3wvddQo6gMnofZ8eIaEbypBTgTxol8Hk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Penetrating+Macrophage-Based+Nanoformulation+for+Periodontitis+Treatment&rft.jtitle=ACS+nano&rft.au=Yan%2C+Na&rft.au=Xu%2C+Junchao&rft.au=Liu%2C+Guolin&rft.au=Ma%2C+Chao&rft.date=2022-11-22&rft.pub=American+Chemical+Society&rft.issn=1936-0851&rft.eissn=1936-086X&rft.volume=16&rft.issue=11&rft.spage=18253&rft.epage=18265&rft_id=info:doi/10.1021%2Facsnano.2c05923&rft.externalDocID=a172996577 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-0851&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-0851&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-0851&client=summon |